Child Health, Nutrition and Microbiome Development
Launched by KHYBER MEDICAL UNIVERSITY PESHAWAR · Mar 19, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Child Health, Nutrition and Microbiome Development," is focused on understanding how the gut microbiome—the community of bacteria in our digestive system—develops in young children living in areas with high rates of malnutrition. The researchers want to explore how malnutrition affects the gut microbiome in children aged 0 to 28 days, particularly in Khyber Pakhtunkhwa, Pakistan, where childhood malnutrition is a serious problem. By studying these children, the trial hopes to find out why some children struggle with malnutrition and how their gut health can be improved.
To participate in this study, children must be healthy infants born to parents living in rural areas of District Swat, and their families should plan to stay in the area for at least a year. Unfortunately, infants with serious medical conditions or those born to very young mothers are not eligible for this trial. Participants can expect to contribute to important research that may help improve the health and nutrition of future generations. It's an opportunity to help scientists learn more about how to support children who are struggling with malnutrition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy infants aged 0 - 28 days
- • Born to parents residing in rural and remote areas of District Swat
- • Living in separate households
- • Parents/caregivers have no plans to move out of the stud site for at least one year after enrollment in the study.
- Exclusion Criteria:
- • Child born to underage (\<18 years old) mother.
- • Infants born with severe acute or chronic medication conditions that require hospitalization or prolonged use of medication or both or the infant is diagnosed with enteropathies.
- • Whose parents refused to provide informed consent to participate in the study.
- • Weight of the child is \<1500 gm.
About Khyber Medical University Peshawar
Khyber Medical University Peshawar is a leading academic institution dedicated to advancing medical education, research, and healthcare in Pakistan. With a commitment to excellence, the university plays a pivotal role in fostering clinical research initiatives that aim to improve patient outcomes and public health. Through its robust infrastructure and collaboration with local and international partners, Khyber Medical University Peshawar conducts innovative clinical trials that adhere to rigorous ethical standards and regulatory guidelines, contributing to the global body of medical knowledge and the development of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kp, Pakistan
Khyber, Kp, Pakistan
Swāt, Kp, Pakistan
Patients applied
Trial Officials
Muhammad Shahzad, PhD
Principal Investigator
Khyber Medical University
Zia Ul Haq, PhD
Study Director
Khyber Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials